These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 2991035

  • 1. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients].
    Gotoh M, Mizuno K, Hashimoto S, Kunii N, Fukuchi S.
    Nihon Naibunpi Gakkai Zasshi; 1985 May 20; 61(5):619-29. PubMed ID: 2991035
    [Abstract] [Full Text] [Related]

  • 2. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system].
    Mizuno K, Gotoh M, Haruyama K, Hashimoto S, Toki T, Matsui J, Fukuchi S.
    Nihon Naibunpi Gakkai Zasshi; 1983 Oct 20; 59(10):1620-9. PubMed ID: 6363144
    [Abstract] [Full Text] [Related]

  • 3. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK, Vlasses PH, Swanson BN, Mojaverian P, Hichens M, Irvin JD, Huber PB.
    Clin Pharmacol Ther; 1982 Jul 20; 32(1):48-53. PubMed ID: 6282527
    [Abstract] [Full Text] [Related]

  • 4. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B, Cubela R, Johnston CI.
    J Hypertens; 1984 Aug 20; 2(4):371-7. PubMed ID: 6099390
    [Abstract] [Full Text] [Related]

  • 5. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Aug 20; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 6. Effects of enalapril maleate (MK-421) on renovascular hypertension.
    Ogawa K, Matsunaga M, Nagai H, Hara A, Koide H, Pak CH, Hirakawa A, Kawai C.
    Tohoku J Exp Med; 1985 Feb 20; 145(2):125-35. PubMed ID: 2986316
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA, Baker KM, Ayers CR, Weaver BA, Lehman MR.
    J Cardiovasc Pharmacol; 1985 Feb 20; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical significance of serum angiotensin I-converting enzyme in essential hypertension].
    Gotoh M.
    Nihon Naibunpi Gakkai Zasshi; 1985 Dec 20; 61(12):1341-57. PubMed ID: 3005063
    [Abstract] [Full Text] [Related]

  • 15. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J, Rabinowe S, Hollenberg NK, Williams GH.
    J Clin Invest; 1985 Apr 20; 75(4):1285-90. PubMed ID: 2985655
    [Abstract] [Full Text] [Related]

  • 16. An overview of the clinical pharmacology of enalapril.
    Davies RO, Gomez HJ, Irvin JD, Walker JF.
    Br J Clin Pharmacol; 1984 Apr 20; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.